Evidence map›Paper›PMID 27266447›Full record

ReviewAdvanced drug delivery reviews2017

Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.

Miles A Miller, Ralph Weissleder

Open access · greenAbstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
13.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Design rules for externally triggered drug uncaging under optical and radiolytic regimes.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. In Vivo Click Chemistry Enables Multiplexed Intravital Microscopy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Miles A MillerCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, Boston, MA 02114, USA.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, Boston, MA 02114, USA; Department of Systems Biology, Harvard Medical School, 200 Longwood Ave, Boston, MA 02115, USA. Electronic address: rweissleder@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · US

Funding

StatisticsP50CA086355 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HILDERBRAND, SCOTT A · 2000 to 2015
$27.8M
Training Grant in Molecular Imaging Research (MGH/HMS)T32CA079443 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2025
$10.1M
Imaging of nanotherapeutic drug actionU01CA206997 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2017 to 2021
$2.9M
Imaging tumor associated macrophage (TAM) functionR01CA206890 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PITTET, MIKAEL, WEISSLEDER, MD, PHD, RALPH · 2017 to 2021
$1.9M
Single Cell Imaging of the HeartR01HL122208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2014 to 2017
$1.7M
NCI NIH HHS P50 CA086355NCI NIH HHS R01 CA206890NCI NIH HHS T32 CA079443NCI NIH HHS U01 CA206997NHLBI NIH HHS HHSN268201000044CNHLBI NIH HHS R01 HL122208
6 · The paper itself

Abstract

Therapeutic nanoparticles (NPs) can deliver cytotoxic chemotherapeutics and other drugs more safely and efficiently to patients; furthermore, selective delivery to target tissues can theoretically be accomplished actively through coating NPs with molecular ligands, and passively through exploiting physiological "enhanced permeability and retention" features. However, clinical trial results have been mixed in showing improved efficacy with drug nanoencapsulation, largely due to heterogeneous NP accumulation at target sites across patients. Thus, a clear need exists to better understand why many NP strategies fail in vivo and not result in significantly improved tumor uptake or therapeutic response. Multicolor in vivo confocal fluorescence imaging (intravital microscopy; IVM) enables integrated pharmacokinetic and pharmacodynamic (PK/PD) measurement at the single-cell level, and has helped answer key questions regarding the biological mechanisms of in vivo NP behavior. This review summarizes progress to date and also describes useful technical strategies for successful IVM experimentation.

Indexed as

Drug CarriersHumansIntravital MicroscopyNanoparticlesSingle-Cell AnalysisDrug Carriersborondipyrromethene (BODIPY, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) (PubChem CID: 14766991)cisplatin (PubChem CID: 2767)docetaxel (PubChem CID: 148124)doxorubicin (PubChem CID: 31703)Drug effluxeribulin mesylate (PubChem CID: 17755248)Extravasationferumoxytol/carboxymethyl dextran-coated hydroxy(oxo)iron: iron (PubChem CID: 49868115)ibrutinib (PubChem CID: 24821094)LiposomeMicrovascular perfusionOrthotopic windowPhagocytepoly(dl-lactic-co-glycolic) acid (PLGA) (PubChem CID: 23111554)poly(ethylene glycol) (PEG) (PubChem CID: 174)Quantum dotsilicon rhodamine dye (SiR-650, [7-(dimethylamino)-5,5-dimethyl-10-(2-methylphenyl)benzo[b] [1]benzosilin-3-ylidene]-dimethylazanium) (PubChem CID: 49779253)Tumor-associated macrophage

Identifiers

PMID27266447
PMCPMC5136524
OpenAlexW2416990306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.